|
1
|
Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset.
|
Blood
|
2012
|
2.57
|
|
2
|
Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells.
|
Proc Natl Acad Sci U S A
|
2004
|
2.49
|
|
3
|
Human Vgamma9Vdelta2 T cells: promising new leads for immunotherapy of infections and tumors.
|
Curr Opin Immunol
|
2006
|
1.56
|
|
4
|
Self/non-self discrimination by human gammadelta T cells: simple solutions for a complex issue?
|
Immunol Rev
|
2007
|
1.50
|
|
5
|
V gamma 9V delta 2 T cell response to colon carcinoma cells.
|
J Immunol
|
2005
|
1.45
|
|
6
|
The molecular basis for modulation of human Vγ9Vδ2 T cell responses by CD277/butyrophilin-3 (BTN3A)-specific antibodies.
|
J Biol Chem
|
2012
|
1.34
|
|
7
|
Potentiation of antigen-stimulated V gamma 9V delta 2 T cell cytokine production by immature dendritic cells (DC) and reciprocal effect on DC maturation.
|
J Immunol
|
2006
|
1.25
|
|
8
|
Direct killing of Epstein-Barr virus (EBV)-infected B cells by CD4 T cells directed against the EBV lytic protein BHRF1.
|
Blood
|
2003
|
1.22
|
|
9
|
CXCR5 identifies a subset of Vgamma9Vdelta2 T cells which secrete IL-4 and IL-10 and help B cells for antibody production.
|
J Immunol
|
2006
|
1.19
|
|
10
|
Early triggering of exclusive IFN-gamma responses of human Vgamma9Vdelta2 T cells by TLR-activated myeloid and plasmacytoid dendritic cells.
|
J Immunol
|
2009
|
1.09
|
|
11
|
CD4 engagement by CD1d potentiates activation of CD4+ invariant NKT cells.
|
Blood
|
2007
|
1.09
|
|
12
|
Cutting edge: CD1d restriction and Th1/Th2/Th17 cytokine secretion by human Vδ3 T cells.
|
J Immunol
|
2013
|
1.05
|
|
13
|
NKG2D costimulates human V gamma 9V delta 2 T cell antitumor cytotoxicity through protein kinase C theta-dependent modulation of early TCR-induced calcium and transduction signals.
|
J Immunol
|
2010
|
1.02
|
|
14
|
IL-21-mediated potentiation of antitumor cytolytic and proinflammatory responses of human V gamma 9V delta 2 T cells for adoptive immunotherapy.
|
J Immunol
|
2009
|
1.01
|
|
15
|
Up-regulation of cytolytic functions of human Vδ2-γ T lymphocytes through engagement of ILT2 expressed by tumor target cells.
|
Blood
|
2011
|
0.93
|
|
16
|
Human Vgamma9Vdelta2 T cells: from signals to functions.
|
Semin Immunol
|
2010
|
0.92
|
|
17
|
Repeated systemic administrations of both aminobisphosphonates and human Vγ9Vδ2 T cells efficiently control tumor development in vivo.
|
J Immunol
|
2013
|
0.89
|
|
18
|
+1 Frameshifting as a novel mechanism to generate a cryptic cytotoxic T lymphocyte epitope derived from human interleukin 10.
|
J Exp Med
|
2002
|
0.88
|
|
19
|
Optimizing anti-CD3 affinity for effective T cell targeting against tumor cells.
|
Eur J Immunol
|
2002
|
0.79
|
|
20
|
Modulation of inflammation through IL-17 production by gammadelta T cells: mandatory in the mouse, dispensable in humans?
|
Immunol Lett
|
2009
|
0.78
|
|
21
|
Full restoration of Brucella-infected dendritic cell functionality through Vγ9Vδ2 T helper type 1 crosstalk.
|
PLoS One
|
2012
|
0.78
|
|
22
|
Synergism and complementarity between human CD1 AND MHC-restricted T cells, two lymphoid subsets directed against distinct antigenic worlds.
|
Front Biosci
|
2005
|
0.76
|
|
23
|
Activated iNKT cells promote Vγ9Vδ2-T cell anti-tumor effector functions through the production of TNF-α.
|
Clin Immunol
|
2011
|
0.76
|
|
24
|
A novel HLA-B18 restricted CD8+ T cell epitope is efficiently cross-presented by dendritic cells from soluble tumor antigen.
|
PLoS One
|
2012
|
0.76
|